| Product NDC: | 68012-309 |
| Proprietary Name: | Uceris |
| Non Proprietary Name: | BUDESONIDE (11.BETA.,16.ALPHA.(S)) |
| Active Ingredient(s): | 9 mg/1 & nbsp; BUDESONIDE (11.BETA.,16.ALPHA.(S)) |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68012-309 |
| Labeler Name: | Santarus, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA203634 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130114 |
| Package NDC: | 68012-309-30 |
| Package Description: | 30 TABLET in 1 BOTTLE (68012-309-30) |
| NDC Code | 68012-309-30 |
| Proprietary Name | Uceris |
| Package Description | 30 TABLET in 1 BOTTLE (68012-309-30) |
| Product NDC | 68012-309 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | BUDESONIDE (11.BETA.,16.ALPHA.(S)) |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130114 |
| Marketing Category Name | NDA |
| Labeler Name | Santarus, Inc |
| Substance Name | BUDESONIDE (11.BETA.,16.ALPHA.(S)) |
| Strength Number | 9 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |